Zago Wagner M.

Chief Scientific OfficerPROTHENA CORP PUBLIC LTD CO (PRTA) · full profile →Form 4 · filed Jul 31, 2026
No Open-Market Flow
Open-Market Buys
$0
Open-Market Sells
$0
Net Open-Market Flow
$0
Transactions
3
2 non-derivative · 1 derivative

Non-Derivative Transactions (Table I)

DateActionSharesPriceValueOwned After
Jul 28, 2026Option exercise(M)51K85K
Jul 28, 2026Disposed to issuer(D)51K$8.56$437K34K

Derivative Transactions (Table II)

DateActionSharesPriceValueOwned After
Jul 28, 2026Option exercise(M)51K$00

Transaction Codes

M
Option exercise / conversion
D
Disposition to the issuer

Data Source & Provenance

Parsed from a single SEC EDGAR Form 4 filing (accession 0000905148-26-003417) within minutes of acceptance. Every field above traces to the original document. Verify it directly:

Build

Build on these Form 4 transactions

The public view is the crawlable proof. The same sourced dataset is available through REST and MCP for agents, research scripts, and back-office tools.